Neuroprotection of Sevoflurane Against Ischemia/Reperfusion-Induced Brain Injury Through Inhibiting JNK3/Caspase-3 by Enhancing Akt Signaling Pathway

Molecular Neurobiology

Volumn 53, Issue 3, 2016, Pages 1661-1671

  Wen, Xiang Ru ^a   Fu, Yan Yan ^a   Liu, Hong Zhi ^a   Wu, Jian ^a   Shao, Xiao Ping ^a   Zhang, Xun Bao ^a   Tang, Man ^a   Shi, Yue ^a   Ma, Kai ^a   Zhang, Fang ^a   Wang, Yi Wen ^a   Tang, Hui ^a   Han, Dong ^a   Zhang, Pu ^a   Wang, Shu Ling ^a   Xu, Zhou ^a   Song, Yuan Jian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Akt1; Caspase 3; Ischemia reperfusion; JNK3; Sevoflurane

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE B; PROTEIN PRAS40; SEVOFLURANE; UNCLASSIFIED DRUG; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; ETHER DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 10; MORPHOLINE DERIVATIVE; NEUROPROTECTIVE AGENT; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HIPPOCAMPAL CA1 REGION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; RAT; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BRAIN INJURIES; COMPLICATION; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANDROSTADIENES; ANIMALS; APOPTOSIS; BRAIN INJURIES; CA1 REGION, HIPPOCAMPAL; CASPASE 3; CHROMONES; ENZYME ACTIVATION; MALE; MAP KINASE KINASE KINASE 5; METHYL ETHERS; MITOGEN-ACTIVATED PROTEIN KINASE 10; MODELS, BIOLOGICAL; MORPHOLINES; NEURONS; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84961139200     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9111-8     Document Type: Article

References (35)

1. Mestriner RG, Miguel PM, Bagatini PB, Saur L, Boisserand LS, Baptista PP, Xavier LL, Netto CA (2013) Behavior outcome after ischemic and hemorrhagic stroke, with similar brain damage, in rats. Behav Brain Res 244:82–89
2. Kim DH, Kim S, Jung WY, Park SJ, Park DH, Kim JM, Cheong JH, Ryu JH (2009) The neuroprotective effects of the seeds of Cassia obtusifolia on transient cerebral global ischemia in mice. Food Chem Toxicol 47:1473–1479
3. Warner DS, McFarlane C, Todd MM, Ludwig P, McAllister AM (1993) Sevoflurane and halothane reduce focal ischemic brain damage in the rat, Possible influence on thermoregulation. Anesthesiology 79:985–992
4. Park HP, Jeong EJ, Kim MH, Hwang JW, Lim YJ, Min SW, Kim CS, Jeon YT (2011) Effects of sevoflurane on neuronal cell damage after severe cerebral ischemia in rats. Korean J Anesthesiol 61:327–331
5. Kolbitsch C, Lorenz IH, Hormann C, Kremser C, Schocke M, Felber S, Moser PL, Hinteregger M et al (2001) Sevoflurane and nitrous oxide increase regional cerebral blood flow (rCBF) and regional cerebral blood volume (rCBV) in a drug-specific manner in human volunteers. Magn Reson Imaging 19:1253–1260
6. 2 reactivity in anterior and posterior cerebral circulation during sevoflurane anesthesia. Anesth Analg 102:560–564
7. Payne RS, Akca O, Roewer N, Schurr A, Kehl F (2005) Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res 1034:147–152
8. Hu X, Zhang Y, Li W, Liu J, Li Y (2013) Preconditioning with sevoflurane ameliorates spatial learning and memory deficit after focal cerebral ischemia-reperfusion in rats. Int J Dev Neurosci 31:328–333
9. Bedirli N, Bagriacik EU, Emmez H, Yilmaz G, Unal Y, Ozkose Z (2012) Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia. J Neurosurg Anesthesiol 24:336–344
10. Yang Q, Dong H, Deng J, Wang Q, Ye R, Li X, Hu S, Dong H et al (2011) Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg 112:931–937
11. Ye Z, Guo Q, Wang N, Xia P, Yuan Y, Wang E (2012) Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation. Neurol Sci 33:239–249
12. Zhang Y, Zhang FG, Meng C, Tian SY, Wang YX, Zhao W, Chen J, Zhang XS et al (2012) Inhibition of sevoflurane postconditioning against cerebral ischemia reperfusion-induced oxidative injury in rats. Molecules 17:341–354
13. Hui L, Pei DS, Zhang QG, Guan QH, Zhang GY (2005) The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation. Brain Res 1052:1–9
14. Bayascas JR (2008) Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways. Cell Cycle 7:2978–2982
15. Downward J (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267
16. Liu BN, Han BX, Liu F (2014) Neuroprotective effect of pAkt and HIF-1 alpha on ischemia rats. Asian Pac J Trop Med 7:221–225
17. Xiong X, Xie R, Zhang H, Gu L, Xie W, Cheng M, Jian Z, Kovacina K et al (2014) PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways. Neurobiol Dis 66:43–52
18. Charette SJ, Lambert H, Landry J (2001) A kinase-independent function of Ask1 in caspase-independent cell death. J Biol Chem 276:36071–36074
19. Zhang TL, Fu JL, Geng Z, Yang JJ, Sun XJ (2012) The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region. CNS Neurosci Ther 18:981–987
20. Feng X, Li J, Liu J, Jin M, Liu X, Du H, Zhang L, Sun Z et al (2011) Protective effect of FK506 on myocardial ischemia/reperfusion injury by suppression of CaN and ASK1 signaling circuitry. Cardiovasc Toxicol 11:18–27
21. Yano S, Morioka M, Fukunaga K, Kawano T, Hara T, Kai Y, Hamada J, Miyamoto E et al (2001) Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 21:351–360
22. Nijboer CH, Bonestroo HJ, Zijlstra J, Kavelaars A, Heijnen CJ (2013) Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage. Neurobiol Dis 54:432–444
23. Junyent F, de Lemos L, Verdaguer E, Folch J, Ferrer I, Ortuno-Sahagun D, Beas-Zarate C, Romero R et al (2011) Gene expression profile in JNK3 null mice: a novel specific activation of the PI3K/AKT pathway. J Neurochem 117:244–252
24. Liu G, Song J, Guo Y, Wang T, Zhou Z (2013) Astragalus injection protects cerebral ischemic injury by inhibiting neuronal apoptosis and the expression of JNK3 after cerebral ischemia reperfusion in rats. Behav Brain Funct: BBF 9:36
25. Manning AM, Davis RJ (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2:554–565
26. Wang Q, Zhang QG, Wu DN, Yin XH, Zhang GY (2007) Neuroprotection of selenite against ischemic brain injury through negatively regulating early activation of ASK1/JNK cascade via activation of PI3K/AKT pathway. Acta Pharmacol Sin 28:19–27
27. Pulsinelli WA, Brierley JB (1979) A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267–272
28. Yu Q, Chu M, Wang H, Lu S, Gao H, Li P, Gan Y, Shi H et al (2011) Sevoflurane preconditioning protects blood-brain-barrier against brain ischemia. Front Biosci 3:978–988
29. Shi H, Sun BL, Zhang J, Lu S, Zhang P, Wang H, Yu Q, Stetler RA et al (2013) miR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioning. CNS Neurol Disord Drug Targets 12:381–391
30. Yang Q, Yan W, Li X, Hou L, Dong H, Wang Q, Dong H, Wang S et al (2012) Activation of canonical notch signaling pathway is involved in the ischemic tolerance induced by sevoflurane preconditioning in mice. Anesthesiology 117:996–1005
31. Wang WY, Wang H, Luo Y, Jia LJ, Zhao JN, Zhang HH, Ma ZW, Xue QS et al (2012) The effects of metabotropic glutamate receptor 7 allosteric agonist N, N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway. Neurosci 205:167–177
32. Song T, Lv LY, Xu J, Tian ZY, Cui WY, Wang QS, Qu G, Shi XM (2011) Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway. Exp Biol Med (Maywood) 236:1427–1436
33. Wen XR, Li C, Zong YY, Yu CZ, Xu J, Han D, Zhang GY (2008) Dual inhibitory roles of geldanamycin on the c-Jun NH2-terminal kinase 3 signal pathway through suppressing the expression of mixed-lineage kinase 3 and attenuating the activation of apoptosis signal-regulating kinase 1 via facilitating the activation of Akt in ischemic brain injury. Neurosci 156:483–497
34. Klawitter J, Klawitter J, Agardi E, Corby K, Leibfritz D, Lowes BD, Christians U, Seres T (2013) Association of DJ-1/PTEN/AKT- and ASK1/p38-mediated cell signalling with ischaemic cardiomyopathy. Cardiovasc Res 97:66–76
35. Gill R, Soriano M, Blomgren K, Hagberg H, Wybrecht R, Miss MT, Hoefer S, Adam G et al (2002) Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J Cereb Blood Flow Metab 22:420–430